Stoke Therapeutics shareholders approve option exchange for RSUs at special meeting

Stoke Therapeutics, Inc.

Stockholders voted 23,393,135 For, 8,352,191 Against, 26,577 Abstained on proposal.
Approved one-time value-neutral exchange of outstanding employee stock options for restricted stock units.
Exchange applies to options under 2014 and 2019 Equity Incentive Plans held by eligible employees.
Proposal was described as approximately value neutral for shareholders.

Key facts

Extracted from this filing and checked against the source text.

Shareholder Votes SEC 8-K Item 5.07 confidence 0.9

Stoke Therapeutics, Inc. shareholders approved Approval of the one-time approximately value neutral exchange of certain outstanding stock options into restricted stock units at the 2023-10-24 meeting.

Outcome: passed
Meeting: 2023-10-24

Exact text from the filing

Approval of the one-time approximately value neutral exchange of certain outstanding stock options issued pursuant to the Company’s 2014 Equity Incentive Plan or the Company’s 2019 Equity Incentive Plan that are held by its eligible employees into restricted stock units: Shares For Shares Against Shares Withheld/Abstaining 23,393,135 8,352,191 26,577

View on SEC.gov

Browse all shareholder votes →

Stoke Therapeutics, Inc. filing history →

Source: SEC EDGAR

accession 0001193125-23-264160

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.